Number of the records: 1
Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091)
SYS 0184242 LBL 00000naa--2200000-a-4500 005 20250607175300.3 008 221108s2022----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng 044 $a xo $c SK 245 10
$a Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091) / $c Maertens J., Drgona L. ... [et al.] 500 $a Clin Infect Dis. 2022 Jul 30 650 12
$7 sllk_us_auth*d015470 $a leukémia myeloidná akútna $2 mesh 650 12
$7 sllk_us_auth*d009190 $a syndrómy myelodysplastické $2 mesh 650 12
$7 sllk_us_auth*d000077336 $a kaspofungín $2 mesh 650 22
$7 sllk_us_auth*d015725 $a flukonazol $2 mesh 650 22
$7 sllk_us_auth*d015996 $a miera prežívania $2 mesh 653 2-
$a vyhodnotenie súboru pacientov 655 -7
$7 sllk_us_auth*d004740 $a abstrakt v angličtine $2 mesh 700 1-
$7 sllk_us_auth*0056924 $a Maertens, J. $4 ant 700 1-
$7 sllk_us_auth*p0063373 $a Drgoňa, Ľuboš $u II. Onkologická klinika LFUK a NOÚ, Bratislava $4 ant 710 2-
$7 sllk_us_auth*0012742 $a Redakcia Onkológia $4 adp 773 0-
$7 nnas $w sllk_us_cat*0183873 $t Onkológia $x 1336-8176 $d Bratislava : SOLEN, 2022 $g Roč. 17, č. 4 (2022), s. 299-300
Number of the records: 1